Allen James Meglin is Director of Organicell Regenerative Medicine, Inc.. Currently has a direct ownership of 14.6 Million shares of OCEL, which is worth approximately $16.8 Million. The most recent transaction as insider was on Dec 21, 2020, when has been sold 1,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.6M
0% 3M change
0% 12M change
Total Value Held $16.8 Million

Allen James Meglin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2020
BUY
Open market or private purchase
-
1,000,000 Added 6.41%
14,589,180 Common Stock
Oct 16 2020
BUY
Open market or private purchase
$50,000 $0.08 p/Share
625,000 Added 4.4%
13,589,180 Common Stock
AJM

Allen James Meglin

Director
Savannah, GA

Track Institutional and Insider Activities on OCEL

Follow Organicell Regenerative Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCEL shares.

Notify only if

Insider Trading

Get notified when an Organicell Regenerative Medicine, Inc. insider buys or sells OCEL shares.

Notify only if

News

Receive news related to Organicell Regenerative Medicine, Inc.

Track Activities on OCEL